Key Statistics for 067080
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (ttm)
|Est. PEG Ratio
|Market Cap (M KRW)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (KRW)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 067080
- Net Income (M/KRW)
Daehwa Pharm Co., Ltd. develops and manufactures a variety of pharmaceutical drugs, such as analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs.
More Company Profile & Key Executives for 067080
|Lee Han-GuChairman/CEO/Co-Rep Director||No Byeong-TaeCo-Rep Director|
|Kim Su-JiHonorary Chairman||Kim Un-JangHonorary Chairman|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.